CSIMarket Company Name, Ticker, Competitors, else..


Iteos Therapeutics Inc   (NASDAQ: ITOS)
Other Ticker:  
 

Iteos Therapeutics Inc

ITOS's Fundamental analysis



Iteos Therapeutics Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Iteos Therapeutics Inc net loss increased from $-32 millions, to $-45 millions in III. Quarter 2024,

• More on ITOS's Growth


Iteos Therapeutics Inc
realized a net loss in trailing twelve months.

Iteos Therapeutics Inc realized cash reduction of $ -1.86 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.42.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.55.


• More on ITOS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 14.64

Iteos Therapeutics Inc
realized net loss in trailing twelve months.

Iteos Therapeutics Inc realized cash outflow of $ -1.86per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.42.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.55.

Iteos Therapeutics Inc Price to Book Ratio is at 0.52 lower than Industry Avg. of 471.52. and higher than S&P 500 Avg. of 0.01

• More on ITOS's Valuation

•  Market Capitalization (Millions $) 330
•  Shares Outstanding (Millions) 43
•  Employees 157
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -121
•  Cash Flow (TTM) (Millions $) -80
•  Capital Exp. (TTM) (Millions $) -3
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 14.64

•  Market Capitalization (Millions $) 330
•  Shares Outstanding (Millions) 43
•  Employees 157
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -121
•  Cash Flow (TTM) (Millions $) -80
•  Capital Exp. (TTM) (Millions $) -3





  Ratio
•   Capital Ratio (MRQ) 9.14
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.14
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com